Logo image of LEN

LENNAR CORP-A (LEN) Stock Fundamental Analysis

NYSE:LEN - US5260571048 - Common Stock

141.88 USD
+3.81 (+2.76%)
Last: 9/5/2025, 8:26:54 PM
141.8 USD
-0.08 (-0.06%)
After Hours: 9/5/2025, 8:26:54 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to LEN. LEN was compared to 62 industry peers in the Household Durables industry. LEN gets an excellent profitability rating and is at the same time showing great financial health properties. LEN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

LEN had positive earnings in the past year.
LEN had a positive operating cash flow in the past year.
Each year in the past 5 years LEN has been profitable.
Each year in the past 5 years LEN had a positive operating cash flow.
LEN Yearly Net Income VS EBIT VS OCF VS FCFLEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

The Return On Assets of LEN (9.38%) is better than 74.19% of its industry peers.
Looking at the Return On Equity, with a value of 14.28%, LEN is in the better half of the industry, outperforming 66.13% of the companies in the same industry.
The Return On Invested Capital of LEN (10.16%) is better than 66.13% of its industry peers.
LEN had an Average Return On Invested Capital over the past 3 years of 12.81%. This is above the industry average of 10.51%.
Industry RankSector Rank
ROA 9.38%
ROE 14.28%
ROIC 10.16%
ROA(3y)10.45%
ROA(5y)10.53%
ROE(3y)15.85%
ROE(5y)16.42%
ROIC(3y)12.81%
ROIC(5y)12.14%
LEN Yearly ROA, ROE, ROICLEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

LEN has a Profit Margin of 9.11%. This is in the better half of the industry: LEN outperforms 75.81% of its industry peers.
In the last couple of years the Profit Margin of LEN has grown nicely.
LEN has a better Operating Margin (12.14%) than 77.42% of its industry peers.
LEN's Operating Margin has improved in the last couple of years.
LEN has a Gross Margin of 13.73%. This is amonst the worse of the industry: LEN underperforms 93.55% of its industry peers.
LEN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.14%
PM (TTM) 9.11%
GM 13.73%
OM growth 3Y-10.07%
OM growth 5Y2.56%
PM growth 3Y-12.02%
PM growth 5Y5.94%
GM growth 3Y-8.58%
GM growth 5Y3%
LEN Yearly Profit, Operating, Gross MarginsLEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), LEN is creating some value.
Compared to 1 year ago, LEN has less shares outstanding
LEN has less shares outstanding than it did 5 years ago.
LEN has a better debt/assets ratio than last year.
LEN Yearly Shares OutstandingLEN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
LEN Yearly Total Debt VS Total AssetsLEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

LEN has an Altman-Z score of 4.68. This indicates that LEN is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.68, LEN is doing good in the industry, outperforming 77.42% of the companies in the same industry.
The Debt to FCF ratio of LEN is 15.73, which is on the high side as it means it would take LEN, 15.73 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 15.73, LEN is in line with its industry, outperforming 48.39% of the companies in the same industry.
LEN has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
LEN's Debt to Equity ratio of 0.19 is fine compared to the rest of the industry. LEN outperforms 66.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 15.73
Altman-Z 4.68
ROIC/WACC1.21
WACC8.43%
LEN Yearly LT Debt VS Equity VS FCFLEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B 20B 25B

2.3 Liquidity

LEN has a Current Ratio of 7.62. This indicates that LEN is financially healthy and has no problem in meeting its short term obligations.
LEN's Current ratio of 7.62 is amongst the best of the industry. LEN outperforms 82.26% of its industry peers.
LEN has a Quick Ratio of 1.02. This is a normal value and indicates that LEN is financially healthy and should not expect problems in meeting its short term obligations.
LEN has a Quick ratio of 1.02. This is comparable to the rest of the industry: LEN outperforms 50.00% of its industry peers.
Industry RankSector Rank
Current Ratio 7.62
Quick Ratio 1.02
LEN Yearly Current Assets VS Current LiabilitesLEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

4

3. Growth

3.1 Past

The earnings per share for LEN have decreased strongly by -17.81% in the last year.
The Earnings Per Share has been growing by 20.01% on average over the past years. This is a very strong growth
The Revenue has decreased by -1.13% in the past year.
Measured over the past years, LEN shows a quite strong growth in Revenue. The Revenue has been growing by 9.75% on average per year.
EPS 1Y (TTM)-17.81%
EPS 3Y3.67%
EPS 5Y20.01%
EPS Q2Q%-47.54%
Revenue 1Y (TTM)-1.13%
Revenue growth 3Y9.32%
Revenue growth 5Y9.75%
Sales Q2Q%-4.43%

3.2 Future

The Earnings Per Share is expected to grow by 9.89% on average over the next years. This is quite good.
LEN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.30% yearly.
EPS Next Y-38.74%
EPS Next 2Y-16.63%
EPS Next 3Y-3.13%
EPS Next 5Y9.89%
Revenue Next Year-1.15%
Revenue Next 2Y0.34%
Revenue Next 3Y2.18%
Revenue Next 5Y5.3%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LEN Yearly Revenue VS EstimatesLEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
LEN Yearly EPS VS EstimatesLEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15 20 25

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.74, which indicates a very decent valuation of LEN.
Compared to the rest of the industry, the Price/Earnings ratio of LEN indicates a somewhat cheap valuation: LEN is cheaper than 61.29% of the companies listed in the same industry.
LEN is valuated cheaply when we compare the Price/Earnings ratio to 27.06, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 14.24, LEN is valued correctly.
The rest of the industry has a similar Price/Forward Earnings ratio as LEN.
When comparing the Price/Forward Earnings ratio of LEN to the average of the S&P500 Index (22.69), we can say LEN is valued slightly cheaper.
Industry RankSector Rank
PE 11.74
Fwd PE 14.24
LEN Price Earnings VS Forward Price EarningsLEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

LEN's Enterprise Value to EBITDA ratio is in line with the industry average.
LEN's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 131.87
EV/EBITDA 9.05
LEN Per share dataLEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The decent profitability rating of LEN may justify a higher PE ratio.
A cheap valuation may be justified as LEN's earnings are expected to decrease with -3.13% in the coming years.
PEG (NY)N/A
PEG (5Y)0.59
EPS Next 2Y-16.63%
EPS Next 3Y-3.13%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.45%, LEN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.72, LEN pays a bit more dividend than its industry peers.
LEN's Dividend Yield is slightly below the S&P500 average, which is at 2.41.
Industry RankSector Rank
Dividend Yield 1.45%

5.2 History

On average, the dividend of LEN grows each year by 65.54%, which is quite nice.
LEN has been paying a dividend for at least 10 years, so it has a reliable track record.
LEN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)65.54%
Div Incr Years1
Div Non Decr Years15
LEN Yearly Dividends per shareLEN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

16.62% of the earnings are spent on dividend by LEN. This is a low number and sustainable payout ratio.
The dividend of LEN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP16.62%
EPS Next 2Y-16.63%
EPS Next 3Y-3.13%
LEN Yearly Income VS Free CF VS DividendLEN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B
LEN Dividend Payout.LEN Dividend Payout, showing the Payout Ratio.LEN Dividend Payout.PayoutRetained Earnings

LENNAR CORP-A

NYSE:LEN (9/5/2025, 8:26:54 PM)

After market: 141.8 -0.08 (-0.06%)

141.88

+3.81 (+2.76%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)06-16 2025-06-16/amc
Earnings (Next)09-18 2025-09-18/amc
Inst Owners98.63%
Inst Owner Change3.08%
Ins Owners1.79%
Ins Owner Change0.2%
Market Cap36.75B
Analysts69.17
Price Target126.81 (-10.62%)
Short Float %5.89%
Short Ratio3.99
Dividend
Industry RankSector Rank
Dividend Yield 1.45%
Yearly Dividend2
Dividend Growth(5Y)65.54%
DP16.62%
Div Incr Years1
Div Non Decr Years15
Ex-Date07-03 2025-07-03 (0.5)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.08%
Min EPS beat(2)-7.71%
Max EPS beat(2)11.86%
EPS beat(4)2
Avg EPS beat(4)4.24%
Min EPS beat(4)-7.71%
Max EPS beat(4)16.11%
EPS beat(8)6
Avg EPS beat(8)6.35%
EPS beat(12)9
Avg EPS beat(12)9.02%
EPS beat(16)11
Avg EPS beat(16)7.19%
Revenue beat(2)2
Avg Revenue beat(2)1.66%
Min Revenue beat(2)1.66%
Max Revenue beat(2)1.66%
Revenue beat(4)3
Avg Revenue beat(4)0.66%
Min Revenue beat(4)-2.32%
Max Revenue beat(4)1.66%
Revenue beat(8)6
Avg Revenue beat(8)1.37%
Revenue beat(12)8
Avg Revenue beat(12)2.36%
Revenue beat(16)12
Avg Revenue beat(16)2.02%
PT rev (1m)-3.9%
PT rev (3m)-12.5%
EPS NQ rev (1m)-0.06%
EPS NQ rev (3m)-24.9%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)-14.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.82%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.04%
Valuation
Industry RankSector Rank
PE 11.74
Fwd PE 14.24
P/S 1.04
P/FCF 131.87
P/OCF 89.7
P/B 1.63
P/tB 1.92
EV/EBITDA 9.05
EPS(TTM)12.09
EY8.52%
EPS(NY)9.97
Fwd EY7.02%
FCF(TTM)1.08
FCFY0.76%
OCF(TTM)1.58
OCFY1.11%
SpS136.57
BVpS87.17
TBVpS73.88
PEG (NY)N/A
PEG (5Y)0.59
Profitability
Industry RankSector Rank
ROA 9.38%
ROE 14.28%
ROCE 13.31%
ROIC 10.16%
ROICexc 10.54%
ROICexgc 20.97%
OM 12.14%
PM (TTM) 9.11%
GM 13.73%
FCFM 0.79%
ROA(3y)10.45%
ROA(5y)10.53%
ROE(3y)15.85%
ROE(5y)16.42%
ROIC(3y)12.81%
ROIC(5y)12.14%
ROICexc(3y)15.1%
ROICexc(5y)13.98%
ROICexgc(3y)19.12%
ROICexgc(5y)17.25%
ROCE(3y)16.78%
ROCE(5y)15.9%
ROICexcg growth 3Y-0.73%
ROICexcg growth 5Y10.92%
ROICexc growth 3Y-5.57%
ROICexc growth 5Y8.18%
OM growth 3Y-10.07%
OM growth 5Y2.56%
PM growth 3Y-12.02%
PM growth 5Y5.94%
GM growth 3Y-8.58%
GM growth 5Y3%
F-Score4
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 15.73
Debt/EBITDA 0.99
Cap/Depr 104.87%
Cap/Sales 0.37%
Interest Coverage 250
Cash Conversion 9.27%
Profit Quality 8.64%
Current Ratio 7.62
Quick Ratio 1.02
Altman-Z 4.68
F-Score4
WACC8.43%
ROIC/WACC1.21
Cap/Depr(3y)101.58%
Cap/Depr(5y)91.5%
Cap/Sales(3y)0.32%
Cap/Sales(5y)0.3%
Profit Quality(3y)86.08%
Profit Quality(5y)96.72%
High Growth Momentum
Growth
EPS 1Y (TTM)-17.81%
EPS 3Y3.67%
EPS 5Y20.01%
EPS Q2Q%-47.54%
EPS Next Y-38.74%
EPS Next 2Y-16.63%
EPS Next 3Y-3.13%
EPS Next 5Y9.89%
Revenue 1Y (TTM)-1.13%
Revenue growth 3Y9.32%
Revenue growth 5Y9.75%
Sales Q2Q%-4.43%
Revenue Next Year-1.15%
Revenue Next 2Y0.34%
Revenue Next 3Y2.18%
Revenue Next 5Y5.3%
EBIT growth 1Y-26.49%
EBIT growth 3Y-1.69%
EBIT growth 5Y12.56%
EBIT Next Year-36.3%
EBIT Next 3Y-7.33%
EBIT Next 5Y4.38%
FCF growth 1Y-94.16%
FCF growth 3Y-3.29%
FCF growth 5Y9.84%
OCF growth 1Y-91.56%
OCF growth 3Y-1.73%
OCF growth 5Y10.15%